DiscoverSpringer Health+ IME: Podcast to PracticeBreakfast bites: Highlights from ADPD 2024™ | S1E2
Breakfast bites: Highlights from ADPD 2024™ | S1E2

Breakfast bites: Highlights from ADPD 2024™ | S1E2

Update: 2024-03-13
Share

Description

Journey to New Era for Alzheimer's Disease

As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024.


In this episode Professor Oskar Hansson summarises anti-amyloid immunotherapy session highlights from onsite at ADPD 2024™

Comments 
loading
In Channel
Breakfast bites: Highlights from ADPD 2024™ | S1E1

Breakfast bites: Highlights from ADPD 2024™ | S1E1

2024-03-1204:51

Breakfast bites: Highlights from ADPD 2024™ | S1E2

Breakfast bites: Highlights from ADPD 2024™ | S1E2

2024-03-1303:39

Breakfast bites: Highlights from CONy 2024 | S1E3

Breakfast bites: Highlights from CONy 2024 | S1E3

2024-03-2505:06

Breakfast bites: Highlights from CONy 2024 | S1E4

Breakfast bites: Highlights from CONy 2024 | S1E4

2024-03-2510:22

Discussing the potential for blood based biomarker use | S1E5

Discussing the potential for blood based biomarker use | S1E5

2024-08-0504:33

Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6

Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6

2024-08-0503:26

The effects of time on blood-based biomarkers | S1E7

The effects of time on blood-based biomarkers | S1E7

2024-08-1502:31

Opportunities for anti-amyloid antibody treatment | S1E8

Opportunities for anti-amyloid antibody treatment | S1E8

2024-11-1303:29

Real-world data on anti-amyloid antibody therapies | S1E9

Real-world data on anti-amyloid antibody therapies | S1E9

2024-11-1304:51

The evolving landscape of PBC: New therapies and future directions | S2E1

The evolving landscape of PBC: New therapies and future directions | S2E1

2024-04-0914:30

Walking the path of PBC: Navigating symptoms and QoL | S2E2

Walking the path of PBC: Navigating symptoms and QoL | S2E2

2024-04-0911:34

Coping with PBC: Treatment challenges and QoL insights | S2E3

Coping with PBC: Treatment challenges and QoL insights | S2E3

2024-06-2518:43

Key CGM Updates and Highlights from the ATTD 2024 Conference | S3E1

Key CGM Updates and Highlights from the ATTD 2024 Conference | S3E1

2024-04-1725:25

Key CGM Updates and Highlights from the ADA 2024 Conference | S3E2

Key CGM Updates and Highlights from the ADA 2024 Conference | S3E2

2024-07-0418:23

Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3

Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3

2024-10-0325:08

Key CGM Updates and Highlights From the 2025 Standards of Care in Diabetes Revision by the ADA | S3E4

Key CGM Updates and Highlights From the 2025 Standards of Care in Diabetes Revision by the ADA | S3E4

2025-03-1710:40

Targeted therapy for ALK-positive NSCLC: A practical case study | S4E1

Targeted therapy for ALK-positive NSCLC: A practical case study | S4E1

2024-06-2506:27

Navigating NSCLC: Merging molecular insights and targeted therapy | S4E2

Navigating NSCLC: Merging molecular insights and targeted therapy | S4E2

2024-06-2507:17

Optimal approaches for resectable ALK-driven NSCLC | S4E3

Optimal approaches for resectable ALK-driven NSCLC | S4E3

2024-06-2508:56

Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1

Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1

2024-07-1809:47

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Breakfast bites: Highlights from ADPD 2024™ | S1E2

Breakfast bites: Highlights from ADPD 2024™ | S1E2

Springer Health+ IME